Description
Developer of therapies for wound healing and anti-infection management. The company develops recombinant human plasminogen that helps in wound healing and offers its product in the form of ear drops for tympanic membrane perforation, enabling people to get rid of irritations.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Angel (individual) | 06-Dec-2021 | $618K | 00.000 | Completed | Generating Revenue | |
2. Angel (individual) | 00.000 | 00.000 | Completed | Startup | ||
1. Accelerator/Incubator | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180326023-A1 | Plasminogen dosage regimen for wound healing | Abandoned | 10-Nov-2015 | 0000000000 | 0 |
JP-2018534306-A | Plasminogen administration plan for wound healing | Pending | 10-Nov-2015 | 0000000000 | |
EP-3373957-A1 | Plasminogen dosage regimen for wound healing | Withdrawn | 10-Nov-2015 | 0000000000 | |
AU-2016352183-A1 | Plasminogen dosage regimen for wound healing | Abandoned | 10-Nov-2015 | 0000000000 | |
CA-3004509-A1 | Plasminogen dosage regimen for wound healing | Pending | 10-Nov-2015 | A61K38/484 |
Name | Representing | Role | Since |
---|---|---|---|
Lars Johansson | Omnio (Drug Discovery) | Chairman of the Board | 000 0000 |
Lars Ohman | Self | Board Member | 000 0000 |
Stefan Nilsson | Self | Board Member | 000 0000 |
Tor Ny Ph.D | Omnio (Drug Discovery) | Co-Founder, Head of Research & Development & Board Member | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Umeå Biotech Incubator | Accelerator/Incubator | 000 0000 | 000000 0 |